Prediction of response to Certolizumab-Pegol in rheumatoid arthritis (PreCePRA) by functional MRI of the brain – Study protocol for a randomized double-blind controlled study

Background: Tumor necrosis factor inhibitors (TNFi) signify a major advance in the treatment of rheumatoid arthritis (RA). However, treatment success initially remains uncertain as approximately half of the patients do not respond adequately to TNFi. Thus, an unmet need exists to better predict ther...

Celý popis

Podrobná bibliografie

Hlavní autoři:	H.M. Schenker, K. Tascilar, L. Konerth, M. Sergeeva, J. Prade, S. Strobelt, A. Kleyer, D. Simon, L. Mendez, M. Hagen, V. Schönau, A. Hueber, J. Roesch, A. Dörfler, A. Hess, G. Schett, J. Rech
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2021-06-01
Edice:	Contemporary Clinical Trials Communications
Témata:	Rheumatoid arthritis functional MRI TNF inhibition Neuroimaging
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S2451865421000715
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!